efficacy against e coli atcc 25922 (ATCC)
Structured Review

Efficacy Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 52741 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12853757-247-30-34
Average 99 stars, based on 52741 article reviews
Images
1) Product Images from "Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential"
Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential
Journal: Journal of Nanobiotechnology
doi: 10.1186/s12951-026-04053-6
Figure Legend Snippet: In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against E. coli 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates
Techniques Used: In Vitro, Incubation
Figure Legend Snippet: Overall antimicrobial mechanisms of IPr. ( A ) Time-kill curves against E. coli 25922 and S. aureus 29213. ( B ) Effect of IPr on outer membrane permeability of E. coli 25922. ( C ) Effect of IPr on cytoplasmic membrane permeability of E. coli 25922. ( D ) IPr-induced cytoplasmic membrane depolarization of E. coli 25922 and S. aureus 29213. ( E ) IPr-induced inhibition of respiratory chain dehydrogenases in E. coli 25922 and S. aureus 29213. ( F ) Accumulation of intracellular ROS in E. coli 25922 and S. aureus 29213. ( G ) Extracellular ATP release in E. coli 25922 and S. aureus 29213. ( H ) Microscopic characterization of IPr-induced bacterial damage, including fluorescence microscopy with live/dead viability staining (scale bar: 400 μm and 200 μm), TEM (scale bar: 500 nm), and SEM (scale bar: 1 μm). Red arrows indicate prominent morphological damage. Data in ( A ), ( B ), ( E ), ( F ) and ( G ) are presented as mean ± SEM, n = 3. Groups with significant differences ( P < 0.05) are labeled with distinct superscripted letters (a-f). All differences between groups are analyzed by one-way ANOVA followed by Duncan post-test analysis
Techniques Used: Membrane, Permeability, Inhibition, Fluorescence, Microscopy, Staining, Labeling
Related Articles
In Vitro:Article Title: Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine Article Snippet: .. Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli , we decided to have this combination tested for Article Title: Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine. Article Snippet: .. Effects of azidothymidine, trimethoprim and uridine on peritoneal E. coli infection in mice Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli, we decided to have this combination tested for Infection:Article Title: Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine Article Snippet: .. Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli , we decided to have this combination tested for Article Title: Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine. Article Snippet: .. Effects of azidothymidine, trimethoprim and uridine on peritoneal E. coli infection in mice Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli, we decided to have this combination tested for Activity Assay:Article Title: Characterization and genome analyses of the novel phages targeting extraintestinal Escherichia coli clones ST131 and ST410. Article Snippet: The rise of multidrug-resistant (MDR) extraintestinal pathogenic Escherichia coli (ExPEC) poses a severe healthcare threat, necessitating alternative treatment strategies such as bacteriophage therapy.. In this study, four lytic phages (EC.W2-9, EC.W5-4, EC.W8-1, and EC.W14-2) were isolated from hospital wastewater and characterized for their efficacy against MDR ExPEC isolates.. A total of 44 ExPEC isolates were analyzed, with 41% belonging to sequence type (ST) 131 and 59% to ST410, all exhibiting MDR phenotypes. Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential Article Snippet: .. Fortunately, IPr maintained strong bactericidal activity against both bacterial strains in the presence of seven physiological ions, with only Ca 2+ and Mg 2+ exerting a modest attenuation of its |
